And the NF-κB pathway activation which also participates in the PHA665752 resistance of TTA1 cells emerged as a molecular mechanism implicated in the development and the therapeutic resistance of thyroid cancers [41]. This evidence concerns the gene NFKB1 and thyroid gland carcinoma.